Screening and Multiple Intervention on Lung Epidemics

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

2,000

Participants

Timeline

Start Date

July 23, 2019

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2026

Conditions
InflammationSmoking CessationDiet ModificationPhysical ActivityLung Cancer
Interventions
DRUG

Cytisine

"Cytisine administration will be randomized 1:1 in standard (40 days)and prolonged treatment (84 days).~Subjects will be educated on how to take the product and informed about possible adverse effects."

DRUG

Acetylsalicylic acid

The treatment will consist of Acetylsalicylic acid at 100mg once a day

OTHER

Diet Modification and Physical Activity Increase

"It will be proposed:~1. an optimal diet with the aim of favoring control of weight, abdominal fat and adequate nutritional status without increasing the levels of IGF-I and inflammatory factors or glycemic peaks, with periodic verification of the results~2. a regular and sustainable physical activity program with periodic verification of the results."

DIAGNOSTIC_TEST

early lung cancer detection

standard treatment for early lung cancer detection with ultra low dose CT

DIAGNOSTIC_TEST

spirometry with CO test

spirometry with CO test

OTHER

anthropometic data collection

anthropometic data collection

OTHER

blood test

blood test to assess the metabolic and inflammatory profile

Trial Locations (1)

20133

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

All Listed Sponsors
collaborator

Istituto Di Ricerche Farmacologiche Mario Negri

OTHER

lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER